Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1391-1400 of 2933 for cancer

Edit search filters
  1. S0820, Adenoma and Second Primary Prevention Trial

    Rochester, MN

  2. Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures after Endotherapy

    Jacksonville, FL

  3. Phase II Venetoclax, Obinutuzumab And Bendamustine In High Tumor Burden Follicular Lymphoma As Front Line Therapy

    Rochester, MN

  4. A Study To Assess The Effectiveness And Safety Of Durvalumab Alone Or Combined With Bevacizumab In High Risk Of Recurrence HCC Patients After Curative Treatment

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Ibrutinib In Treating Patients With Relapsed Hairy Cell Leukemia

    Rochester, MN

  6. Lenalidomide Plus Rituximab Followed By Lenalidomide Versus Rituximab Maintenance For Relapsed/Refractory Follicular, Marginal Zone Or Mantle Cell Lymphoma.

    Rochester, MN

  7. Apixaban In Preventing Secondary Cancer Related Blood Clots In Cancer Patients Who Have Completed Anticoagulation Therapy

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, Rochester, MN

  8. Study To Determine The Impact Of Advanced Magnetic Resonance Imaging (MRI) Using 18F-DOPA (A Chemical Tracer That Highlights Certain Cells During Imaging) During Planning For Proton Beam Radiation Therapy.

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Extracellular Impact Of Ultrasound-induced Blood-brain Barrier Disruption

    Rochester, MN

  10. Study Evaluating The Safety And Effectiveness Of JCARH125 In Subjects With Relapsed And/or Refractory Multiple Myeloma (EVOLVE)

    Rochester, MN

.

Mayo Clinic Footer